Skip to content

Effect of Low-calorie Diet and Orange Juice on Body Weight and Metabolic Parameters of Obese Subjects

Low-calorie Diet Combined With Orange Juice Results in Weight Loss: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02914249
Acronym
LCD-OJ-OBESE
Enrollment
78
Registered
2016-09-26
Start date
2015-09-30
Completion date
2016-08-31
Last updated
2016-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Orange juice, Low-calorie diet, Body composition, Weight-loss, Metabolic biomarkers, Obese

Brief summary

This study aimed to verify if combination of a low calorie diet and orange juice consumption results in weight loss and ameliorates metabolic obesity-related biomarkers.

Detailed description

Seventy-eight obese subjects aged 36 ± 1 years and BMI of 33 ± 3 kg were randomly divided into two parallel groups: (1) orange juice (n = 39), composed of individuals subjected to a diet low caloric diet and plus intake of 500 ml orange juice; (2) control (n = 39) composed of individuals subjected to a diet low in calories. The recruitment process began in September 2015, the intervention was carried out from October 2015 to January 2016, and the data analysis started in February 2016. The sample number took into account variances on body weight with a type I error α = 0.05 and a type II error β = 0.2 (80% power). The minimum sample size should have 36 individuals per group (n = 72), considering an approximately 15% dropout rate. Thus, the final sample size of study was constituted by 39 individuals per group (n = 78). Primary and secondary endpoints were the reduction of weight and modification of the levels of obesity-related metabolic biomarkers, respectively. Normality and homogeneity of data were tested. T-test was conducted to identify possible differences between OJ and control groups at baseline. A linear mixed-effects model was apply to determine the time effect within and between groups (post hoc), and P significance was set up ≤ 0.05. The assessment of body composition, metabolic biomarkers and food intake were analyzed over a 12-week intervention.

Interventions

Nutritionists prescribed a low-calorie diet that was estimated from total energy expenditure (TEE) for each individual minus 500 kcal per day (30% TEE). Both groups had the same diet plan based on individual weight. The dietary plan was composed of six meals/day: breakfast (fat-free milk and coffee; whole-grain bread with margarine, and an apple); snack 1 (250 mL OJ / banana and free-fat yogurt); lunch (brown rice, beans, grilled lean meat, salad, cooked vegetables); snack 2 (250 mL OJ / free-fat yogurt with oatmeal); dinner (brown rice, beans, grilled lean meat, cooked vegetables and salad); and snack 3 (salty crackers or oat cookies, tea without sugar). Body composition measurements were collected (monthly); blood samples and dietary questionnaires (every two weeks).

Sponsors

National Association of Exporters of Citrus Juices
CollaboratorOTHER
Citrosuco Company
CollaboratorINDUSTRY
São Paulo State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 30 \> BMI \< 40 kg/m2

Exclusion criteria

* Dieting last year, * Use of drugs, vitamins and dietary supplements * Alcohol consumption (\> 20 g alcohol/d) * Intense physical activity (\> 5 hours/week).

Design outcomes

Primary

MeasureTime frame
Body-weight12 weeks

Secondary

MeasureTime frame
Body lean mass12 weeks
Body fat mass12 weeks
Percentage of body fat12 weeks
Ratio waist/hip12 weeks
Glucose12 weeks
Insulin12 weeks
Homeostatic Model assessment of Insulin Resistance12 weeks
Total cholesterol12 weeks
LDL-cholesterol12 weeks
Body mass index (BMI)12 weeks
Non-HDL-cholesterol12 weeks
Triglycerides12 weeks
hsCRP12 weeks
Alkaline phosphatase12 weeks
Aspartate transaminase12 weeks
Alanine transaminase12 weeks
Gamma-glutamyl transferase12 weeks
Antioxidant capacity (ABTS)12 weeks
Lipid peroxidation (TBARS)12 weeks
HDL-cholesterol12 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026